Utilization of alpha-ketoisocaproate for protein synthesis in uremic rats.
We have recently shown that the nutritional efficiency, R, of alpha-ketoisocaproate (KIC) as a substitute for leucine, defined as the ratio of the dose of leucine to the dose of KIC (on a leucine-free diet) for equal growth, can be evaluated isotopically: 14C-KIC and 3H-leucine are administered p.o.; six hours later, 14C/3H in the leucine of whole body protein, divided by 14C/3H in the injectate, gives a value distinguishable from R assessed in the same animals by growth experiments. To see how chronic uremia affects R, 11/12 nephrectomized rats and sham-operated controls were fed a regular diet for 15 days and then given these isotopes p.o. Six hours later, R, measured in whole body protein, and in the protein of brain, heart, muscle, salivary gland, liver, and the kidney remnant was significantly greater than in sham-operated controls. The greatest difference (39%) was seen in liver protein and the smallest difference (19%) in muscle. Thus chronic uremia increases the efficiency, relative to leucine, with which KIC is utilized for protein synthesis in all of these organs and in the body as a whole. Possible explanations are discussed.
D000818:Animals; D001798:Blood Proteins / Q000032:analysis; D001835:Body Weight; D007651:Keto Acids / Q000008:administration & dosage / Q000378:metabolism / Q000494:pharmacology*; D007676:Kidney Failure, Chronic / Q000178:diet therapy; D007930:Leucine / Q000378:metabolism; D009392:Nephrectomy; D014176:Protein Biosynthesis; D011868:Radioisotopes; D051381:Rats; D011919:Rats, Inbred Strains / Q000254:growth & development; D012078:Renal Artery Obstruction; D014018:Tissue Distribution; D014511:Uremia / Q000178:diet therapy* / Q000378:metabolism
D001798:Blood Proteins; D007651:Keto Acids; D011868:Radioisotopes; C013082:alpha-ketoisocaproic acid; D007930:Leucine